Reaction

Macrocytosis reporting signals

Last recalculated 2026-09-14T18:28:35.993900+00:00 · 1,152 reports · 27 co-occurring drugs

As of the last recalculation, Macrocytosis appears in 1,152 FAERS reports alongside 27 co-occurring drug terms. The strongest observed disproportionality signal is ZIDOVUDINE (PRR 64.7).

Important: FAERS is a spontaneous, voluntary, unverified reporting system. PRR and ROR identify reporting patterns for investigation; they are not incidence rates and do not establish causation.
DrugCo-reportsPRRROR
Zidovudine4664.764.9
Ribociclib6136.836.9
Gentamicin1723.823.9
Ampicillin1022.022.0
Ampicillin Sodium1022.022.0
Ciclesonide1621.521.5
Gentamicin Sulfate1719.719.7
Letrozole5918.218.2
Anastrozole Tablets2118.018.0
Letrozole Tablets4316.716.8
Fulvestrant2916.216.3
Zinc2014.914.9
Zinc Chloride2014.814.8
Zinc Gluconate2114.814.8
Nevirapine714.114.1
Lamivudine2213.113.1
Anastrozole2512.612.6
Eplerenone811.411.4
Sulfasalazine4711.311.3
Hydroxyurea1311.211.2
Palbociclib418.08.0
Eculizumab227.47.4
Ethyl Alcohol117.47.4
Olaparib87.07.0
Vigabatrin56.26.2
Alcohol125.65.6
Abemaciclib54.54.5

Related reactions

Data source: openFDA FAERS. See the OpenPV methodology and limitations.